ADRA2A antibody (AA 218-374) (FITC)
Quick Overview for ADRA2A antibody (AA 218-374) (FITC) (ABIN7143809)
Target
See all ADRA2A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 218-374
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Alpha-2A adrenergic receptor protein (218-374AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
-
Alternative Name
- ADRA2A
-
Background
-
Background: Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol.
Aliases: ADA2A_HUMAN antibody, ADRA2 antibody, ADRA2A antibody, ADRA2R antibody, ADRAR antibody, Adrenergic alpha 2A receptor antibody, Alpha 2 adrenergic receptor subtype C10 antibody, Alpha 2A adrenergic receptor antibody, Alpha 2AAR subtype C10 antibody, Alpha-2 adrenergic receptor subtype C10 antibody, alpha-2-adrenergic receptor, platelet type antibody, Alpha-2A adrenergic receptor antibody, Alpha-2A adrenoceptor antibody, Alpha-2A adrenoreceptor antibody, Alpha-2AAR antibody, ALPHA2AAR antibody, OTTHUMP00000058849 antibody, ZNF32 antibody
-
UniProt
- P08913
-
Pathways
- EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
Target
-